DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.S. Food and Drug Administration (FDA) ...

Baxter International Inc BAX has issued an urgent correction for its Spectrum V8 and Spectrum IQ infusion pumps, applicable in the U.S. and Puerto Rico, due to a ...

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

Baxter recalled over 277,000 infusion pumps due to the risk of the device failing to alarm users of repeated upstream occlusion events. The SIGMA Spectrum Infusion Pump with Master Drug Library ...

Baxter International Inc. BAX recently announced that it has received the CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for the Evo IQ Syringe Infusion ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s ...

Baxter Healthcare has issued a recall for some Spectrum infusion pumps due to a potential defect involving missing motor mounting screws, which could lead to interruptions, delays or incorrect dosing ...

Leading provider of renal and hospital products cum services, Baxter International, Inc. BAX, announced that its Sigma Spectrum Infusion System was nominated as the best-in-class by a report of the ...

DEERFIELD, Ill., December 11, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The ...